Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
NCT00401778
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
RAD001
Sponsor
Emory University